Trade SAB Biotherapeutics, Inc. - SABS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.08 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 2.8 |
| Open | 2.68 |
| 1-Year Change | 235% |
| Day's Range | 2.68 - 2.78 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 2.73 | -0.03 | -1.09% | 2.76 | 2.80 | 2.73 |
| Jul 24, 2024 | 2.68 | -0.07 | -2.55% | 2.75 | 2.75 | 2.68 |
| Jul 23, 2024 | 2.68 | -0.14 | -4.96% | 2.82 | 2.82 | 2.68 |
| Jul 22, 2024 | 2.80 | 0.06 | 2.19% | 2.74 | 2.88 | 2.74 |
| Jul 19, 2024 | 2.69 | -0.29 | -9.73% | 2.98 | 2.98 | 2.69 |
| Jul 18, 2024 | 2.90 | 0.00 | 0.00% | 2.90 | 2.90 | 2.90 |
| Jul 17, 2024 | 2.90 | -0.08 | -2.68% | 2.98 | 3.04 | 2.90 |
| Jul 16, 2024 | 2.93 | -0.05 | -1.68% | 2.98 | 3.00 | 2.93 |
| Jul 15, 2024 | 2.93 | 0.02 | 0.69% | 2.91 | 2.93 | 2.91 |
| Jul 12, 2024 | 2.90 | 0.02 | 0.69% | 2.88 | 2.90 | 2.88 |
| Jul 11, 2024 | 3.08 | 0.22 | 7.69% | 2.86 | 3.08 | 2.86 |
| Jul 10, 2024 | 2.78 | 0.03 | 1.09% | 2.75 | 2.78 | 2.75 |
| Jul 9, 2024 | 2.79 | 0.06 | 2.20% | 2.73 | 2.81 | 2.71 |
| Jul 8, 2024 | 2.78 | 0.05 | 1.83% | 2.73 | 2.79 | 2.73 |
| Jul 5, 2024 | 2.75 | 0.00 | 0.00% | 2.75 | 2.75 | 2.73 |
| Jul 3, 2024 | 2.82 | 0.00 | 0.00% | 2.82 | 2.82 | 2.82 |
| Jul 2, 2024 | 2.98 | 0.16 | 5.67% | 2.82 | 2.98 | 2.73 |
| Jul 1, 2024 | 2.89 | 0.02 | 0.70% | 2.87 | 2.99 | 2.87 |
| Jun 28, 2024 | 3.01 | 0.11 | 3.79% | 2.90 | 3.01 | 2.90 |
| Jun 27, 2024 | 2.78 | -0.03 | -1.07% | 2.81 | 2.81 | 2.78 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
SAB Biotherapeutics, Inc. Company profile
About SAB Biotherapeutics Inc
SAB Biotherapeutics, Inc., formerly Big Cypress Acquisition Corp., is a clinical-stage biopharmaceutical company. The Company offers therapeutic engine called the DiversitAb platform, to produce a new class of specifically targeted, polyclonal antibodies without the need for human donors. Its DiversitAb platform enables a production of polyclonal antibody therapies with the to address the emergence, mutation, and diversity of modern health challenges including COVID-19, seasonal influenza, Type 1 diabetes, and cancers. Its product candidates include SAB-176, SAB-185, SAB-142 and SAB-181. The Company is developing new class of immunotherapies, leveraging the native human immune response, across therapeutic categories including infectious disease immune system disorders and immuno-oncology.
Financial summary
BRIEF: For the nine months ended 30 September 2021, SAB Biotherapeutics Inc revenues was not reported. Net income totaled to $440K.
| Industry: | Biotechnology & Medical Research (NEC) |
2100 East 54Th Street North
Suite 202
SIOUX FALLS
SOUTH DAKOTA 57104
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com